首页> 美国卫生研究院文献>Molecules >Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid
【2h】

Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid

机译:通过与烟酸的缀合的缀合物自动合成氟-18标记的CXCR4配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The C-X-C motif chemokine receptor 4 (CXCR4) is a seven-transmembrane G protein-coupled receptor that is overexpressed in numerous diseases, particularly in various cancers and is a powerful chemokine, attracting cells to the bone marrow niche. Therefore, CXCR4 is an attractive target for imaging and therapeutic purposes. The goal of this study is to develop an efficient, reproducible, and straightforward method to prepare a fluorine-18 labeled CXCR4 ligand. 6-[18F]Fluoronicotinic acid-2,3,5,6-tetrafluorophenyl ester (6-[18F]FPy-TFP) and nicotinic acid N-hydroxysuccinimide ester (6-[18F]SFPy) have been prepared using ‘fluorination on the Sep-Pak’ method. Conjugation of 6-[18F]SFPy or 6-[18F]FPy-TFP with the alpha-amino group at the N terminus of the protected T140 precursor followed by deprotection, yielded the final product 6-[18F]FPy-T140. The overall radiochemical yields were 6–17% (n = 15, decay-corrected) in a 90-min radiolabeling time with a radiochemical purity >99%. 6-[18F]FPy-T140 exhibited high specific binding and nanomolar affinity for CXCR4 in vitro, indicating that the biological activity of the peptide was preserved. For the first time, [18F]SFPy has been prepared using ‘fluorination on the Sep-Pak’ method that allows rapid automated synthesis of 6-[18F]FPy-T140. In addition to increased synthetic efficiency, this construct binds with CXCR4 in high affinity and may have potential as an in vivo positron emission tomography (PET) imaging agent. This radiosynthesis method should encourage wider use of this PET agent to quantify CXCR4 in both research and clinical settings.
机译:C-X-C基序趋化因子受体4(CXCR4)是七跨膜G蛋白偶联受体,其在许多疾病中过表达,特别是在各种癌症中,是一种强大的趋化因子,吸引细胞对骨髓利基。因此,CXCR4是用于成像和治疗目的的有吸引力的目标。本研究的目标是开发一种高效,可重复和直接的方法,以制备氟-18标记的CXCR4配体。使用“氟化” SEP-PAK'方法。 6- [18F] SFPY或6- [18F] FPY-TFP与受保护T140前体的N末端的α-氨基缀合,然后脱保护,得到最终产物6- [18F] FPY-T140。在90分钟的放射性标记时间内,整体放射化学产率为6-17%(n = 15,衰减校正),其放射性化纯度> 99%。 6- [18F] FPY-T140在体外表现出对CXCR4的高特异性结合和纳米摩尔亲和力,表明肽的生物活性被保存。首次,[18F]已经使用“氟化术源于SEP-PAK”方法制备了SFPY,其允许快速自动合成6-[18F] FPY-T140。除了增加的合成效率外,该构建体在高亲和力中与CXCR4结合,并且可以具有体内正电子发射断层扫描(PET)成像剂的潜力。这种辐射合成方法应鼓励更广泛地使用该宠物剂,以在研究和临床环境中量化CXCR4。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号